Tiziana Life Sciences - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Brookfield completes $3bn Oaktree buyout as credit platform reaches $365 bn

Williams to buy Momentum Midstream for $5.5bn as Haynesville LNG strategy accelerates

Snap revenue jumps 19% as AI advertising tools revive $SNAP investor confidence

Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test

Read More

Pharma Industry News

Tiziana Life Sciences strengthens intranasal foralumab development with Renaissance Lakewood partnership

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA), a clinical-stage biotechnology company focused on immunomodulation therapies, has announced a strategic…

byPallavi Madhiraju

February 23, 2025

Read More

Pharma Industry News

Tiziana Life Sciences to launch phase 2 trial of Foralumab in Covid-19

Tiziana Life Sciences said that it plans to launch a phase 2 clinical trial to evaluate the nasal…

March 30, 2021

web analytics